Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ciprodiazole vs Separate Ciprofloxacin and Metronidazole in Pelvi-abdominal Infections
NCT05863832Phase 4Unknown
- Sponsor
- Minapharm Pharmaceuticals
- Start
- Aug 2021
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of metronidazole + ciprofloxacin in Pelviabdominal infection, surgical site infection (SSI), sponsored by Minapharm Pharmaceuticals. Status: unknown.
02
Drugs
metronidazole + ciprofloxacin
03
Conditions
Pelviabdominal infectionsurgical site infection (SSI)
Beyond the preview
Go deeper on NCT05863832.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05863832.